Retraction: Pioglitazone, a PPARÎ³ Agonist, Suppresses CYP19 Transcription: Evidence for Involvement of 15-Hydroxyprostaglandin Dehydrogenase and BRCA1.

Subbaramaiah, Kotha; Howe, Louise R; Zhou, Xi Kathy; Yang, Peiying; Hudis, Clifford A; Kopelovich, Levy; Dannenberg, Andrew J

Subbaramaiah, Kotha; Howe, Louise R; Zhou, Xi Kathy; Yang, Peiying; Hudis, Clifford A; Kopelovich, Levy; Dannenberg, Andrew J.

Cancer Prev Res (Phila) ; 15(6): 411, 2022 06 02.

Article in En | MEDLINE | ID: mdl-35652223

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245248
https://dx.doi.org/10.1158/1940-6207.CAPR-22-0204

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancer Prev Res (Phila) Journal subject: NEOPLASIAS Year: 2022 Document type: Article

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245248
https://dx.doi.org/10.1158/1940-6207.CAPR-22-0204

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancer Prev Res (Phila) Journal subject: NEOPLASIAS Year: 2022 Document type: Article